Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome - Tatebe, Harutsugu; Kasai, Takashi; Ohmichi, Takuma; Kishi, Yusuke; Kakeya, Tomoshi; Waragai, Masaaki; Kondo, Masaki; Allsop, David; Tokuda, Takahiko (Molecular neurodegeneration, 2017)
Keywords: Aged; Aged, 80 and over; Alzheimer Disease - blood; Alzheimer Disease - diagnosis; Alzheimer Disease - pathology; Alzheimer's disease; Amyloid beta-Peptides - blood; Biological markers; Biomarkers - blood; Brain - metabolism; Brain research; Case-Control Studies; Development and progression; Diagnosis; Down syndrome; Down Syndrome - blood; Down Syndrome - diagnosis; Down Syndrome - pathology; Female; Humans; Male; Phosphorylation; Pilot Projects; Plasma biomarker; Simoa; Tau phosphorylated at threonine 181 (p-tau181); tau Proteins - blood; Simoa; Down syndrome; Alzheimer’s disease; Plasma biomarker; Tau phosphorylated at threonine 181 (p-tau181)